The EPS projection of Mylan Inc. (NASDAQ:MYL) for period quarter closed 2016-12-31 is $1.4.
The EPS estimates given 30-days and 1 week ago were $1.4 and $1.4, correspondingly. This number 90 and 60 days before was $1.4 and $1.4 respectively. Yet, from last week, the change in EPS prediction is -0.02%.
For the quarter ended 2 mean estimate is $1.4 based on 8 EPS estimations. As on 2016-08-09 estimated EPS was $1.16 showing surprise of $0.01, or 0.87%. Following the given predictions, the standard deviation is $0.04.
The upgrade count for EPS revisions was 0 a week earlier paralleled to negative revisions of 4. In last 60-days and 1- month, the upgrade in EPS reviews were 1 and 1 correspondingly, though for a quarter and 120-days ago, it was 2 and 2 in that sequence.
The negative reviews of EPS in the last 60-days and 1-month were 3 and 3 in that order. But, a quarter and 120-days ago, this numeral was 2 and 2 correspondingly.
EPS reviews downgrade and upgrade for last 18 days were 3 and 2, correspondingly.
Quarterly Sales Estimates
The mathematical mean of apparent yearly sales of Mylan Inc. (NASDAQ:MYL) is $3227.776 and the median is $3228. The estimate is stated by 5 analysts for the fiscal 2016.
The highest yearly projection is $3302 and lowest sales mark is $3144.68. This results a standard deviation of $70.739.
Almost 5 have reviewed sales target for better in the past week and 5 have downgraded forecasts. Subject to the stated estimates, the intended change in disclosed target from the past week is -1.18%.
Nearly 5 revised sales predictions for better over the past month and 5 have downgraded forecasts. It suggests an average deviation of -2.511% across given estimates.
Just about 5 have revised sales forecast up over the quarter and 5 have downgraded forecasts, hinting to a deviation of -1.185%.
1 Chart Pattern Every Investor Should Know
This little-known pattern preceded moves of 578% in ARWR, 562% in LCI, 513% in ICPT, 439% in EGRX, 408% in ADDUS and more...